☀ DIFFERENT IDEA, DIFFERENT RESULT



Principles underlying the palliative approach to care include:

1. Attention to symptom management and the relief of suffering
2. Providing psychosocial and spiritual care
3. Focusing on quality of life
4. Caring for both the person and chosen family/caregivers, including during bereavement if needed
5. Multidisciplinary team approach
6. Involvement early in the illness trajectory alongside curative treatment
7. Living well until death, accepting death as a natural part of life

 https://web.archive.org/web/20200913041224/http://bc-cpc.ca/cpc/wp-content/uploads/2019/02/2019-02-22-Integration-of-a-PAC.pdf

 

CAREGIVERS

Caregivers may be defined
as unpaid, informal providers
of one or more physical,
social, practical, and emotional tasks.

In terms of their relationship
to the patient,they may be a friend,
partner, ex-partner, sibling,
parent, child, or other blood
or non-blood relative.


https://www.tandfonline.com/doi/full/10.1179/1743291X13Y.0000000056

 

Palliative care allows for medical therapies, but focuses on:

  • Improving quality of life
  • Relieving symptoms (for example pain) and stress
  • Reaching the best possible function (for example, daily activities, physical activity, and self-care)
  • Helping with decision-making about end-of-life care
  • Providing emotional support to patients and their families
https://www.stanfordchildrens.org/en/topic/default?id=palliative-care-90-P03053

Most common symptoms in palliative care
https://ejhp.bmj.com/content/ejhpharm/19/1/34.full.pdf

Did you know...
https://training.caresearch.com.au/learner/course/viewcourse/lid,0/cid,10019/pid,10843
 

Joint Declaration and Statement of Commitment on Palliative Care and Pain Treatment as Human Rights

    1.  Identify,  develop  and  implement  strategies for the recognition of palliative care and pain treatment as fundamental human rights.
    2.  Work with governments and policy makers to adopt the necessary changes in legislation to ensure appropriate care of patients with life-limiting conditions.
    3.  Work with policy makers and regulators to identify and eliminate regulatory and legal barriers that interfere with the rational use of controlled medications.
    4.  Advocate  for  improvements  in  access  to and availability of opioids and other medications  required  for  the  effective  treatment  of  pain  and  other  symptoms  common  in  palliative  care,  including  special formulations and appropriate medications for children.
    5.  Advocate  for  adequate  resources  to  be made available to support the implementation of palliative care and pain treatment services and providers where needed.
    6.  Advocate for academic institutions, teaching hospital and universities to adopt the necessary practices and changes needed to ensure  that  palliative  care  and  pain  positions,  resources,  personnel,  infrastructures, review boards and systems are created and sustained.
    7.  Encourage  and  enlist  other  international and national palliative care, pain treatment,related organizations, associations, federations  and  interested  parties  to  join  this global campaign for the recognition of palliative care and pain treatment as human rights.

https://www.tandfonline.com/doi/full/10.1080/15360280802537274


Advance care planning is defined as discussing and planning for care in the future when the person may no longer have decision-making capacity.

Lactulose

Use:

  • Constipation, faecal incontinence related to constipation.
  • Hepatic encephalopathy (portal systemic encephalopathy) and coma.

Dose:

Constipation:
By mouth: initial dose twice daily then adjusted to suit patient
  • Neonate: 2.5 mL/dose twice a day
  • Child 1 month-11 months: 2.5 mL/dose 1-3 times daily
  • Child 1year-4 years: 5 mL/dose 1-3 times daily
  • Child 5-9 years: 10 mL/dose 1-3 times daily
  • Child 10-17 years: 15 mL/dose 1-3 times daily.

Hepatic encephalopathy:
  • Child 12-17 years: use 30-50mL three times daily as initial dose. Adjust dose to produce 2-3 soft stools per day.
Notes:
  • Licensed for constipation in all age groups. Not licensed for hepatic encephalopathy in children.
  • Increases colonic bacterial flora (macrogols do not).
  • Side effects may cause nausea and flatus, with colic especially at high doses. Initial flatulence usually settles after a few days.
  • Precautions and contraindications; Galactosaemia, intestinal obstruction. Caution in lactose intolerance.
  • Use is limited as macrogols are often better in palliative care. However the volume per dose of macrogols is 5-10 times greater than lactulose and may not be tolerated in some patients.
  • Lactulose is less effective than macrogols, or sodium picosulfate for opioid induced constipation in ambulatory palliative care patients.
  • Sickly taste.
  • Onset of action can take 36-48 hours.
  • May be taken with water and other drinks.
  • May be administered via NG tube or gastrostomy. Dilution with 2-3x the volume of water will reduce the viscosity of the solution and aid administration. As the site of action is the colon, lactulose will have a therapeutic effect if it is delivered directly into the stomach or jejunum. Administer using the above method.
  • 15 mL/day is 14 kcal so unlikely to affect diabetic or ketogenic diets.
  • Does not irritate or directly interfere with gut mucosa.
  • Available as oral solution 10 g/15 mL or 680 mg/1 mL. Cheaper than Movicol (macrogol).
Association for Paediatric Palliative Medicine Master Formulary 2020 (5th edition)
https://www.appm.org.uk/guidelines-resources/appm-master-formulary/

Management of Ascites in Palliative Care
https://bit.ly/AscitesPC

Managing pain and other symptoms - End of life care
  • It can feel very difficult to speak about your illness or the fact you're dying, but talking with your loved ones can help. You or your family and friends may even find it a relief to have the subject out in the open, even if you find it upsetting.
  • Not talking can create worries or distance between you and the people who are important to you, even if you are usually very close. Talking about your illness and death can help you feel closer and more able to deal with the future and your worries together.
 https://www.nhs.uk/conditions/end-of-life-care/controlling-pain-and-other-symptoms/


Essential medicines in palliative care
https://idhdp.com/media/362593/palliat-med-2014-cleary-291-2.pdf
https://www.who.int/selection_medicines/committees/expert/19/applications/PalliativeCare_8_A_R.pdf

There are several common symptoms that may cause distress in dying patients. Ordering medications ahead of time, ‘anticipatory prescribing’, ensures prompt management of these symptoms when they occur.
https://www.sahealth.sa.gov.au/

Management of Constipation in Adult Patients Receiving Palliative Care
https://www.gov.ie/en/collection/b34c3e-management-of-constipation-in-adult-patients-receiving-palliative-ca/
OVERDOSE OPIOID PREVENTION

Palliative Performance Scale (PPS, version 2) is an 11-point scale designed to measure patients’ performance status in 10% decrements from 100% (healthy) to 0% (death) based on five observable parameters: ambulation, ability to do activities, self-care, food/fluid intake, and consciousness level.

Module 6 Recognising Deteriorating Clients

NECN - PALLIATIVE-CARE-GUIDELINES

Below you'll find links to CCPs developed by CCO for the stable, transitional, and end of life stages. Palliative Care Collaborative CCPs

The Palliative Performance Scale (PPS) has been shown to be both valid and useful for a broad range of palliative care patients: those with advanced cancer diagnoses or life-threatening non-cancer diagnoses in clinics, hospitals, or hospices.

Levels of Palliative Care

Key points to consider in the pharmacological management of end-of-life (terminal) symptoms include:
  • Confirm the patient and/or their Substitute Decision Maker (SDM) are aware that the patient is dying and support the use of medicines to manage end-of-life (terminal) symptoms.
  • Prescribe medicines based on careful assessment of the dying patient's condition and symptoms.
  • Regularly reassess treatment so the doses are proportionate to the severity of symptoms.
  • Cease any medications that have minimal therapeutic benefit in the terminal phase of life.
  • Consider the burden associated with how medicines are given, minimising the potential for side effects.
  • Consider administering medicines via the subcutaneous route - the least invasive and most reliable route in the dying.
  • Write up PRN orders for intermittent symptoms and to cover possible breakthrough events for persistent symptoms.
  • Ensure that medicines are easily accessible when needed by writing up the medicines in advance (see Anticipatory prescribing).
  • Identify the cause of problems and then manage in the context of the patient's preferences: remembering some things are irreversible and are a part of the dying process.
https://apps.caresearch.com.au/palliAGED/Prescribing-guidance

B.C. INTER-PROFESSIONAL PALLIATIVE SYMPTOM MANAGEMENT GUIDELINES

END OF LIFE SYMPTOM MANAGEMENT ALGORITHM

WHO - ESSENTIAL MEDICINES IN PALLIATIVE CARE

Comprehensive Advanced Palliative Care Education (CAPCE)

APPROACHING THE END OF LIFE

Patients are ‘approaching the end of life’ when they are likely to die within the next 12 months.
This includes patients whose death is imminent (expected within a few hours or days) and those with:
  • advanced, progressive, incurable conditions
  • general frailty and co-existing conditions that mean they are expected to die within 12 months existing conditions
  • if they are at risk of dying from a sudden acute crisis in their condition
  • life-threatening acute conditions caused by sudden catastrophic events.
Also applies to those extremely premature neonates whose prospects for survival are known to be very poor, and to patients who are diagnosed as being in a persistent vegetative state (PVS), for whom a decision to withdraw treatment may lead to their death. (Download)

PALLIATIVE CARE RESOURCES

Analysis of available evidence suggested 11 symptoms occurring in the advanced stages and end of life stage for the mortality conditions identified which are priorities in palliative care:
• Anorexia
• Anxiety
• Constipation
• Delirium
• Depression
• Diarrhoea
• Dyspnea
• Fatigue
• Nausea and vomiting
• Pain
Respiratory tract secretions
Fifteen medications were identified as essential for the treatments of these symptoms.

 


Oooookay kan, Bro!


Popular Posts

THE NEED FOR PALLIATIVE CARE

→ fifty-two million people die each year → it is estimated that tens of millions of people die with unrelieved suffering → about five mil...